Predictors of institutionalization in dementia: A three year longitudinal study

Journal of Alzheimer's Disease

Volumn 40, Issue 1, 2014, Pages 221-226

  Brodaty, Henry ^a   Connors, Michael H ^a   Xu, Jing ^a   Woodward, Michael ^b   Ames, David ^b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NATIONAL AGEING RESEARCH INSTITUTE   (Australia)

Author keywords

Alzheimer's disease; dementia; institutionalization; longitudinal; nursing home; survival analysis

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; MEMANTINE; NEUROLEPTIC AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; AUSTRALIA; CAREGIVER BURDEN; CLINICAL DEMENTIA RATING; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; DRUG USE; FEMALE; FRONTOTEMPORAL DEMENTIA; FUNCTIONAL DISEASE; HALLUCINATION; HUMAN; INSTITUTIONALIZATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROPSYCHIATRY; PRIORITY JOURNAL;

ALZHEIMER'S DISEASE; DEMENTIA; INSTITUTIONALIZATION; LONGITUDINAL; NURSING HOME; SURVIVAL ANALYSIS;

AGED; AGED, 80 AND OVER; AUSTRALIA; DEMENTIA; FEMALE; HUMANS; INSTITUTIONALIZATION; LONGITUDINAL STUDIES; MALE; OBSERVATION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 84901806070     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131850     Document Type: Article

References (22)

1. Gaugler J, Duval S, Anderson K, Kane R (2007) Predicting nursing home admission in the U.S: A meta-analysis. BMC Geriat 7, 13.
2. Gaugler JE, Yu F, Krichbaum K, Wyman JF (2009) Predictors of nursing home admission for persons with dementia. Med Care 47, 191-198.
3. Luppa M, Luck T, Brähler E, König H-H, Riedel-Heller SG (2008) Prediction of institutionalisation in dementia. Dement Geriatr Cogn Disord 26, 65-78.
4. Birks J. (2006) Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev, CD005593.
5. Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M (2008) Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline. Ann Intern Med 148, 379-397.
6. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, van den Bussche H (2005) Cholinesterase inhibitors for patients with Alzheimer's disease: Systematic review of randomised clinical trials. BMJ 331, 321-323.
7. Schneider LS, Insel PS, Weiner MW (2011) Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Neurol 68, 58-66.
8. Sona A, Zhang P, Ames D, Bush AI, Lautenschlager NT, Martins RN, Masters CL, Rowe CC, Szoeke C, Taddei K, Ellis KA (2012) Predictors of rapid cognitive decline in Alzheimer's disease: Results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of ageing. Int Psychogeriatr 24, 197-204.
9. Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Juszczak E, Yu L-M, Jacoby R (2009) The dementia antipsychotic withdrawal trial (DART-AD): long-termfollow-upofarandomised placebo-controlled trial. Lancet Neurol 8, 151-157.
10. Billioti de Gage S, Bégaud B, Bazin F, Verdoux H, Dartigues J-F, Pérès K, Kurth T, Pariente A (2012) Benzodiazepine use and risk of dementia: Prospective population based study. BMJ 345, e6231.
11. Brodaty H, Woodward M, Boundy K, Ames D, Balshaw R (2011) Patients in Australian memory clinics: Baseline characteristics and predictors of decline at six months. Int Psychogeriatr 23, 1086-1096.
12. Morris JC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43, 2412-2414.
13. O'Bryant SE, Waring SC, Cullum M, Hall J, Lacritz L, Massman PJ, Lupo PJ, Reisch JS, Doody R (2008) Staging dementia using clinical dementia rating scale sum of boxes scores: A Texas Alzheimer's research consortium study. Arch Neurol 65, 1091-1095.
14. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
15. Cummings JL (1997) The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology 48, S10-S16.
16. Hébert R, Carrier R, Bilodeau A (1988) The Functional Autonomy Measurement System (SMAF): Description and validation of an instrument for the measurement of handicaps. Age Ageing 17, 293-302.
17. Bédard M, Molloy DW, Squire L, Dubois S, Lever JA, O'Donnell M (2001) The Zarit Burden Interview:A new short version and screening version. Gerontologist 41, 652-657.
18. Australian Institute of Health and Welfare. (2012) Dementia in Australia (Cat. no. AGE 70), AIHW, Canberra, Australia.
19. Xu J. (2013) Cox proportional hazard model estimation under dependent censoring by maximum penalized likelihood, Mac-quarie University, Sydney, Australia.
20. Huang X, Zhang N (2008) Regression survival analysis with an assumed copula for dependent censoring: A sensitivity analysis approach. Biometrics 64, 1090-1099.
21. Chen Y-H (2010) Semiparametric marginal regression analysis for dependent competing risks under an assumed copula. J R Stat Soc Series B Stat Methodol 72, 235-251.
22. Cerejeira J, Lagarto L, Mukaetova-Ladinska E (2012) Behavioral and psychological symptoms of dementia. Front Neurol 3, 1-21.